About the Author: Jeff Kozloff brings more than 25 years of leadership experience across pharmaceutical, clinical, and commercial software. He has scaled multiple investor-backed companies through critical growth phases, including serving as CEO of Verilogue and TrialScope. He also currently serves as Chairman of the Board at ProofPilot. On April 28, 2026, the FDA announced … Read more
Most research sites are already tracking KPIs. Almost none are tracking them in a way that’s consistent, reliable, or usable in real time. That was the premise behind our recent webinar, KPIs Every Research Site Should Be Tracking (And How to Automate Them), hosted by John Harvey, Director of Enterprise Sales, and Meganne Forrestall, Product … Read more
Most site leaders feel confident in their operational visibility. The data tells a more complicated story. That tension sits at the center of the RealTime Reports: Trial Start-Up, Visibility and Performance Benchmarks Survey, a study of clinical research professionals across independent sites, multi-site networks, and large site organizations. Respondents aren’t early-stage operations. They’re managing significant complexity: 43% are running more … Read more
The operating model for clinical research is shifting. Protocols are becoming more complex — more endpoints, more procedures, more oversight. In tandem, clinical research site networks and multi-site organizations are scaling rapidly, expanding across more studies, more sites, and more complex portfolios. But execution hasn’t kept pace. While trial complexity has accelerated, operational visibility has not. For sponsors and CROs, … Read more
Watch the Replay: The eClinical Command Center: Rethinking the Research Operating Model for AMCs and Hospitals  Most Academic Medical Centers (AMCs) and hospital-based research organizations don’t lack technology. They’re operating in environments where that technology was never designed to work together. Over time, research operations have been built around tools that are familiar, accessible, and often free. Individually, these tools work. But … Read more
Clinical research sites rarely struggle with opportunity. What they struggle with is capacity. Clinical research coordinators (CRCs) are buried in regulatory binders, monitors occupy office space for days at a time, and the sheer volume of manual transcription creates a hard ceiling on growth. A site may have the investigators, the patient population, and even … Read more
As clinical research site networks grow, one issue consistently rises to the top: the financial reporting inside their Clinical Trial Management System (CTMS) isn’t built for scale. Many organizations begin with a basic CTMS, but as sites expand across locations, sponsors, and complex protocols, financial complexity increases, and system limitations become glaringly visible. This is why more multi-site … Read more
Why integration alone fails in enterprise clinical trials, and what AMCs, hospitals, and health systems need instead  Academic Medical Centers and large health systems have invested heavily in research technology, especially over the past decade. Most operate with electronic data capture systems, regulatory document repositories, Clinical Trial Management Systems (CMTS), financial platforms, and internal collaboration tools.  From … Read more
Why Site Network Leaders Need a New Layer of Operational Intelligence to Scale, Compete, and Win  Site networks have become the dominant operational model in clinical research. Sponsors and CROs increasingly rely on networks to deliver consistent performance across multiple geographies, investigators, and patient populations.  This shift has elevated the role of site network leadership. The … Read more
AI Can Read the Trial Registry. Institutions Still Have to Run the Trials. For decades, clinical research teams have relied on the same public source of truth to understand the global trial landscape: ClinicalTrials.gov. It’s where sponsors register studies, where regulators ensure transparency, and where research institutions look to understand what trials exist, who is running them, and how … Read more
Complete the form below to access the full report.Â